Document Detail


Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET).
MedLine Citation:
PMID:  22824435     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Several recent randomized trials comparing everolimus-eluting stent (EES) and sirolimus-eluting stent (SES) reported similar outcomes. However, only one trial was powered for a clinical endpoint, and no trial was powered for evaluating target-lesion revascularization (TLR). METHODS AND RESULTS: Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial is a prospective multicenter randomized open label trial comparing EES with SES in Japan. The trial was powered for evaluating non-inferiority of EES relative to SES in terms of TLR. From February and July 2010, 3197 patients were randomly assigned to receive either EES (1597 patients) or SES (1600 patients). At 1-year, the primary efficacy endpoint of TLR occurred in 65 patients (4.3%) in the EES group, and in 76 patients (5.0%) in the SES group, demonstrating non-inferiority of EES to SES (P non-inferiority<0.0001, and P superiority=0.34). Cumulative incidence of definite stent thrombosis was low and similar between the 2 groups (0.32% versus 0.38%, P=0.77). Angiographic sub-study enrolling 571 patients (EES: 285 patients, and SES: 286 patients) demonstrated non-inferiority of EES relative to SES regarding the primary angiographic endpoint of in-segment late loss (0.06±0.37mm versus 0.02±0.46mm, P non-inferiority<0.0001, and P superiority=0.24) at 278±63 days after index stent implantation. CONCLUSIONS: One-year clinical and angiographic outcome after EES implantation was non-inferior to and not different from that after SES implantation in a stable coronary artery disease population with relatively less complex coronary anatomy. One-year clinical outcome after both EES- and SES-use was excellent with low rate of TLR and very low rate of stent thrombosis. CLINICAL TRIAL REGISTRATION INFORMATION: clinicaltrials.gov; Identifier: NCT01035450.
Authors:
Takeshi Kimura; Takeshi Morimoto; Masahiro Natsuaki; Hiroki Shiomi; Keiichi Igarashi; Kazushige Kadota; Kengo Tanabe; Yoshihiro Morino; Takashi Akasaka; Yoshiki Takatsu; Hideo Nishikawa; Yoshito Yamamoto; Yoshihisa Nakagawa; Yasuhiko Hayashi; Masashi Iwabuchi; Hisashi Umeda; Kazuya Kawai; Hisayuki Okada; Kazuo Kimura; Charles A Simonton; Ken Kozuma
Related Documents :
18022495 - Application of the timi risk score in ed patients with cocaine-associated chest pain.
22570845 - Total knee arthroplasty in rheumatoid arthritis.
10512435 - Charnley low-friction arthroplasty in rheumatoid patients: a survival study up to 20 ye...
11965455 - Preoperative determinants of an esophageal lengthening procedure in laparoscopic antire...
10830345 - Percutaeous radiofrequency facet rhizotomy--experience with 118 procdedures and reappra...
8760975 - The value of duplex surveillance after endovascular intervention for femoropopliteal ob...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-23
Journal Detail:
Title:  Circulation     Volume:  -     ISSN:  1524-4539     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Kyoto University Graduate School of Medicine, Kyoto, Japan;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Comprehensive Evaluation of Rhythm Monitoring Strategies for the Detection of Atrial Fibrillation ...
Next Document:  Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute ...